CLINICAL PRACTICE GUIDANCE FOR RADIOTHERAPY PLANNING AFTER INDUCTION CHEMOTHERAPY IN LOCOREGIONALLY ADVANCED HEAD-AND-NECK CANCER

被引:82
|
作者
Salama, Joseph K. [1 ]
Haddad, Robert I. [2 ]
Kies, Merril S. [3 ]
Busse, Paul M. [4 ]
Dong, Lei [3 ]
Brizel, David M. [5 ]
Eisbruch, Avraham [6 ]
Tishler, Roy B. [2 ]
Trotti, Andy M. [7 ]
Garden, Adam S. [3 ]
机构
[1] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA
[2] Brigham & Womens Hosp, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
[5] Duke Univ, Med Ctr, Duke Comprehens Canc Ctr, Durham, NC 27710 USA
[6] Univ Michigan, Ann Arbor, MI 48109 USA
[7] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2009年 / 75卷 / 03期
关键词
Induction chemotherapy; Intensity-modulated radiotherapy; Radiotherapy planning; Head-and-neck cancer; INTENSITY-MODULATED RADIOTHERAPY; LOCALLY ADVANCED HEAD; SQUAMOUS-CELL CARCINOMA; STAGE NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY; CONCURRENT CHEMORADIOTHERAPY; FLUOROURACIL; IRRADIATION; CISPLATIN; DOCETAXEL;
D O I
10.1016/j.ijrobp.2008.11.059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The use of induction chemotherapy (IC) for locoregionally advanced head-and-neck cancer is increasing. The response to IC often causes significant alterations in tumor volume and location and shifts in normal anatomy. Proper determination of the radiotherapy (RT) targets after IC becomes challenging, especially with the use of conformal and precision RT techniques. Therefore, a consensus conference was convened to discuss issues related to RT planning and coordination of care for patients receiving IC. Methods and Materials: Ten participants with special expertise in the various aspects of integration of IC and RT for the treatment of locoregionally advanced head-and-neck cancer, including radiation oncologists, medical oncologists, and a medical physicist, participated. The individual members were assigned topics for focused, didactic presentations. Discussion was encouraged after each presentation, and recommendations were formulated. Results: Recommendations and guidelines emerged that emphasize up-front evaluation by all members of the head-and-neck management team, high-quality baseline and postinduction planning scans with the patient in the treatment position, the use of preinduction target volumes, and the use of full-dose RT, even in the face of a complete response. Conclusion: A multidisciplinary approach is strongly encouraged. Although these recommendations were provided primarily for patients treated with IC, many of these same principles apply to concurrent chemoradiotherapy without IC. A rapid response during RT is quite common, requiring the development of two or more plans in a sizeable fraction of patients, and suggesting the need for similar guidance in the rapidly evolving area of adaptive RT. (C) 2009 Elsevier Inc.
引用
收藏
页码:725 / 733
页数:9
相关论文
共 50 条
  • [1] Induction Chemotherapy for Locoregionally Advanced Head and Neck Cancer: Past, Present, Future?
    Hanna, Glenn J.
    Haddad, Robert I.
    Lorch, Jochen H.
    ONCOLOGIST, 2013, 18 (03) : 288 - 293
  • [2] Cisplatin Eligibility Issues and Alternative Regimens in Locoregionally Advanced Head and Neck Cancer: Recommendations for Clinical Practice
    Szturz, Petr
    Cristina, Valerie
    Gomez, Ruth Gabriela Herrera
    Bourhis, Jean
    Simon, Christian
    Vermorken, Jan B.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [3] Induction chemotherapy for locally advanced head and neck cancer
    Calais, G.
    Chapet, S.
    Ruffier-Loubiere, A.
    Bernadou, G.
    CANCER RADIOTHERAPIE, 2013, 17 (5-6): : 498 - 501
  • [4] Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer
    Seiwert, Tanguy Y.
    Melotek, James M.
    Blair, Elizabeth A.
    Stenson, Kerstin M.
    Salama, Joseph K.
    Witt, Mary Ellyn
    Brisson, Ryan J.
    Chawla, Apoorva
    Dekker, Allison
    Lingen, Mark W.
    Kocherginsky, Masha
    Villaflor, Victoria M.
    Cohen, Ezra E. W.
    Haraf, Daniel J.
    Vokes, Everett E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (01): : 21 - 29
  • [5] Induction chemotherapy (ICT) and sequential therapy (ST) in locoregionally advanced head and neck cancer
    Vermorken, Jan B.
    ORAL ONCOLOGY, 2011, 47 : S12 - S13
  • [6] Efficacy and Feasibility of Induction Chemotherapy and Radiotherapy plus Cetuximab in Head and Neck Cancer
    Rampino, M.
    Bacigalupo, A.
    Russi, E.
    Schena, M.
    Lastrucci, L.
    Iotti, C.
    Reali, A.
    Musu, A.
    Balcet, V.
    Piva, C.
    Bustreo, S.
    Munoz, F.
    Ragona, R.
    Corvo, R.
    Ricardi, U.
    ANTICANCER RESEARCH, 2012, 32 (01) : 195 - 199
  • [7] The Role of Radiotherapy in the Definitive and Postoperative Treatment of Advanced Head and Neck Cancer
    Semrau, Robert
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 (06) : 347 - 352
  • [8] Induction chemotherapy in head and neck cancer - Boon or bane?
    Mall, Aprajita
    Negi, Preety
    Philip, Ashwin Oommen
    Kingsley, Pamela A.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (02) : 420 - 425
  • [9] Concurrent chemotherapy and radiotherapy for head and neck cancer
    Burri, Ryan J.
    Lee, Nancy Y.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (03) : 293 - 302
  • [10] Predictive Factors for Completion of TPF Induction Chemotherapy in Patients With Locally Advanced Head and Neck Cancer
    Nakano, Kenji
    Seto, Akira
    Sasaki, Toru
    Shimbashi, Wataru
    Fukushima, Hirofumi
    Yonekawa, Hiroyuki
    Mitani, Hiroki
    Takahashi, Shunji
    ANTICANCER RESEARCH, 2019, 39 (08) : 4337 - 4342